MedTrace Logo

Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.

NCT00227188 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 408

Last updated 2012-11-29

No results posted yet for this study

Summary

The aim of this study is to evaluate the postlicensure effectiveness of Prevnar in the prevention of IPD in the Spanish paediatric population (children younger than 5 years)

Conditions

  • Invasive Pneumococcal Disease

Interventions

DRUG

Pneumococcal 7-valent conjugate vaccine Prevnar

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-05-31
Primary Completion
2005-12-31
Completion
2005-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00227188 on ClinicalTrials.gov